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Abstract Fas is a cell surface molecule that mediates apoptosis, but the intracellular mechanisms leading to apoptosis are not well understood. It 
is known that diethylmaleate (DEM)-induced cell death can be blocked by substances with antioxidant activity. Here we have studied whether 
antioxidants have any effect on Fas-mediated apoptosis and show that they are not able to block Fas-mediated apoptosis. Therefore, it seems that 
reactive oxygen intermediate (ROI)-dependent and -independent mechanisms which lead to apoptosis do exist. Fas-mediated apoptosis probably 
proceeds via a ROI-independent pathway. 
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1. Introduction 
Elimination of unwanted cells in multicellular organism pro- 
ceeds via programmed cell death, in most cases, morphologi- 
cally, recognized as apoptosis. Apoptosis can be induced by 
various chemicals, death factors or deprivation of growth fac- 
tors [1,2]. 
Fas and tumor necrosis factor receptor (TNF-R) are cell 
surface proteins which can mediate apoptosis either by stimula- 
tion with the corresponding ligand or specific agonistic mono- 
clonal antibodies [3,4]. However, cytoplasmic proteins and sec- 
ond messengers involved in the signal transduction pathway 
leading to apoptosis are not known. 
Diethylmaleate (DEM) reduces cellular stores of glutathione 
by forming a thioether conjugate in a reaction catalyzed by 
glutathione-S-transferase [5], and reactive oxygen intermedi- 
ates (ROIs) accumulating in the cells induce cell death [6]. A 
neuronal cell line overexpressing Bcl-2 was almost completely 
protected against DEM-induced cell death [6] suggesting that 
Bcl-2 and DEM act in the same signal transduction pathway 
leading to cell death. And it was proposed that Bcl-2 prevents 
cell death by decreasing the net cellular generation of ROIs 
[6,7], Since Fas-mediated apoptosis i also partially inhibited by 
Bcl-2 [8], we address the question whether Fas-mediated apop- 
tosis needs the action of ROIs [9-11]. Here, we have tested 
several antioxidants for their ability to block cell death induced 
by either anti-human Fas antibody or DEM in Fas-overex- 
pressing fibroblasts. We show that only DEM-induced cell 
death can be blocked by the antioxidants we have tested. 
2. Materials and methods 
2.1. Reagents 
Deferoxamine (desferrioxamine mesylate), L-7-glutamyl-L-cys- 
teinylglycyl-O-ethyl ester (GSH-OEt), glutathione (GSH), glutathione 
L-7-glutamyl-L-cysteine (7-GluCys), ct-Tocopherol and catalase were 
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Abbreviations: ROI, reactive oxygen intermediates; TNF, tumor necro- 
sis factor; TNF-R, tumor necrosis factor receptor; DEM, diethyl- 
maleate; HO °, hydroxyl radical; H202, hydrogen peroxide; GSH, 
glutathione; GSH-OEt, L-7-glutamyl-L-cysteinylglycyl-O-ethyl ster; 
7-GluCys, L-7-glutamyl-L-cysteine. 
purchased from Sigma Chemical Co. The monoclonal nti-human Fas 
IgM antibody was obtained from MBL (Japan). Recombinant murine 
TNF was kindly provided by Dr. D.V. Goeddel (Genentech). 
2.2. Cell death assay 
LBl cells are murine L929 fibroblasts tably overexpressing human 
Fas [3]. Cells were treated with the antioxidants, followed by induction 
of apoptosis as described in the figure legends. Living cells were stained 
with Crystal violet as described [3]. Absorbance at 540 nm was meas- 
ured using an automated micro-ELISA autoreader. 
3. Results 
To examine the effects of several antioxidants on Fas-medi- 
ated apoptosis we have used L929 transformants stably overex- 
pressing human Fas (LB 1) [3]. When these cells were incubated 
with the anti-Fas antibody, murine TNF or DEM, almost all 
cells were dead after approximately 6 h. TNF kills these cells 
only in the presence of actinomycin D or cycloheximide, 
whereas these substances are not required for killing mediated 
by Fas but they accelerated Fas-mediated apoptosis (data not 
shown). 
Deferoxamine is an iron chelator and it prevents the forma- 
tion of the hydroxyl radical (HO °) from hydrogen peroxide 
(H202) via the Fenton and Haber-Weiss reaction [11]. LB1 cells 
were incubated with several non-toxic oncentrations of defer- 
oxamine, and apoptosis was induced by an anti-Fas antibody, 
TNF or DEM (Fig. 1). The anti-Fas antibody completely killed 
the cells whereas there was a high protection against DEM- 
induced cell death by deferoxamine in a dose-dependent man- 
ner (Fig. 1). 
The most common atural and lipophilic antioxidant ~-toco- 
pherol very likely protects against membrane lipid peroxida- 
tion. It could react with lipid peroxyl and alkoxyl radicals which 
are generated by the action of ROIs [11]. ct-Tocopherol also 
showed a slight but significant protection against DEM- 
induced but not against anti-Fas antibody- or TNF-induced 
cell death (Fig. 2). 
In the following set of experiments he involvement of gluta- 
thione (GSH) [12] in cell death was determined. It has been 
shown that GSH-OEt can be transported into cells and there- 
after is split intracellularly into glutathione [13]. 7-GluCys is a 
precursor of glutathione [12]. GSH itself, GSH-OEt (Fig. 3) or 
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Fig. 1. LB1 cells were preincubated for 2 h with the indicated concen- 
trations of deferoxamine (Def.). Cell death was induced by treating the 
cells overnight with either 0.1 /tg/ml anti-Fas antibody, 0.01 /~g/ml 
murine TNF, or 0.0037% DEM. Anti-Fas antibody- and TNF-treat- 
ment was in the presence of 50/tg/ml actinomycin D. Cells were stained 
and counted as described in section 2. The assays were done in quadru- 
plicate, and mean values are expressed as the percentage of surviving 
cells incubated with the anti-oxidant alone. The standard eviation was 
less than 15%. 
7'-GluCys (Fig. 4) in the indicated non-toxic oncentrations did 
not show any effect on Fas- or TNF-R-mediated apoptosis, 
whereas they were able to block DEM-induced cell death. This 
indicates that GSH works as protective agent against DEM-  
induced but not Fas- or TNF-R-mediated apoptosis. 
Catalase which catalyzes the dismutation of H20 z also 
showed an approximately 2-fold protection against DEM-in- 
duced cell death but no significant protection against anti-Fas 
antibody- or TNF-induced apoptosis (Fig. 4). Vitamin C had 
no effect on Fas- and TNF-R-mediated apoptosis but showed 
a weak inhibition on DEM-induced cell death (data not 
shown). In addition, og-nitro-L-arginine, an inhibitor of nitric 
oxide synthase, the antioxidants thioredoxin, dimethyl sulfox- 
ide, thiourea, or butylated hydroxyanisol could not block Fas- 
mediated apoptosis (data not shown). 
4. Discussion 
It has been proposed that redox modulation may play a role 
in the regulation of cell death [6,7]. That is, substances that 
increase the oxidation state of a cell (like H~O~ or DEM) induce 
apoptosis and at higher concentrations they lead to necrosis. 
In these systems antioxidants can be used to inhibit apoptosis. 
Here, we could not detect any protective ffect of antioxidants 
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Fig. 2. LB1 cells were preincubated for 2 h with 0.01% ct-tocopherol 
(~-Toc) and cell death was induced and determined as described for 
Fig. 1. 
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Fig. 3. LBI cells were preincubated for 2 h with the indicated concen- 
trations of GSH or GSH-OEt and cell death was induced and deter- 
mined as described for Fig. 1. 
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Fig. 4. LB1 ceils were preincubated for 2 h with the indicated concen- 
trations or 7-GluCys or 10/lg/ml catalase and cell death was induced 
and determined as described for Fig. 1 except that 0.1/lg/ml murine 
TNF was used. 
on Fas-mediated apoptosis, which indicates that Fas-mediated 
apoptosis does not proceed via an increase of the cellular oxida- 
tion level. 
Reduced GSH is used intracellularly to reduce numerous 
oxidizing compounds including ROIs. It also protects proteins 
with sulfhydryl groups from oxidation. DEM inactivates these 
functions of GSH by binding to its reactive sulfhydryl group 
[5]. The resulting increase of the intracellular oxidation state 
then leads to cell death as already mentioned. Accordingly, all 
antioxidants we have tested showed some protective ffect on 
DEM-induced eath, while they were not able to block Fas- 
mediated apoptosis. Therefore, it is very likely that ROIs are 
not necessary for Fas- or TNF-R-mediated apoptosis and that 
Fas- or TNF-R use a mechanism different from that induced 
by DEM leading to cell death. Bcl-2 may inhibit apoptosis by 
blocking several signal transduction pathways including ROI- 
dependent and ROI-independent ones. The partial inhibition 
of Fas-mediated apoptosis by Bcl-2 [8] could therefore be due 
to an inhibition of a ROI-independent step. 
Previously, Schulze-Osthoff etal. [14] have observed an in- 
hibitory effect of antioxidants on TNF-R-mediated cytotox- 
icity, and suggested that ROIs generated from the mitochon- 
drial respiratory chain serve as second messengers for TNF- 
mediated cytotoxicity. Here, we could not detect any effects of 
antioxidants on TNF-R- as well as Fas-mediated apoptosis. 
Although the TNF-R-mediated apoptotic pathways may be 
different among different cell types, these results uggest that 
ROIs may not be essential for TNF-R-mediated apoptosis. The 
p55 TNF-R and Fas carry a similar domain (a death domain), 
which is essential for TNF-R or Fas-mediated apoptosis 
[15,16]. The fact that apoptosis induced by Fas or TNF-R 
cannot be blocked by antioxidants suggests a similar pathway 
for TNF-R-mediated and Fas-mediated apoptosis. However, it 
seems that TNF-R and Fas use distinct pathways to induce 
apoptosis, because manganous superoxide dismutase induced 
by pretreatment with TNF, can protect TNF-R-mediated ap- 
optosis but not Fas-mediated apoptosis [17]. The inability of 
Fas to activate the transcription factor NF-xB (unpublished 
results), which can be activated by TNF [18], agrees with the 
above notion. Identification of molecules which associate with 
the cytoplasmic region of TNF-R or Fas would be necessary 
to understand the apoptotic mechanism ediated by those re- 
ceptors. 
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